Encompass Health (NYSE:EHC) Releases FY24 Earnings Guidance

Encompass Health (NYSE:EHC) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $3.86-4.11 for the period, compared to the consensus estimate of $3.98. The company issued revenue guidance of $5.250-5.325 billion, compared to the consensus revenue estimate of $5.25 billion.

Analysts Set New Price Targets

A number of analysts recently issued reports on the stock. Raymond James reissued a strong-buy rating and set a $95.00 price target (up from $85.00) on shares of Encompass Health in a report on Friday. William Blair reissued an outperform rating on shares of Encompass Health in a report on Wednesday, February 7th. Royal Bank of Canada reissued an outperform rating and set a $83.00 price target on shares of Encompass Health in a report on Friday, February 9th. Truist Financial increased their price objective on shares of Encompass Health from $82.00 to $86.00 and gave the company a buy rating in a report on Friday, February 9th. Finally, Mizuho increased their price objective on shares of Encompass Health from $93.00 to $95.00 and gave the company a buy rating in a report on Thursday. Eight analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of Buy and a consensus target price of $86.56.

Encompass Health Trading Down 0.3 %

EHC stock traded down $0.26 during mid-day trading on Friday, hitting $82.47. 706,619 shares of the company were exchanged, compared to its average volume of 756,857. The company has a quick ratio of 1.28, a current ratio of 1.37 and a debt-to-equity ratio of 1.14. The firm has a market capitalization of $8.26 billion, a P/E ratio of 22.29, a PEG ratio of 1.50 and a beta of 0.94. The business has a fifty day simple moving average of $78.25 and a 200-day simple moving average of $70.87. Encompass Health has a 12-month low of $57.55 and a 12-month high of $85.84.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.19. The company had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.27 billion. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. Encompass Health’s revenue was up 13.4% compared to the same quarter last year. During the same quarter last year, the firm posted $0.88 earnings per share. On average, equities research analysts predict that Encompass Health will post 4.04 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 0.73%. The ex-dividend date was Thursday, March 28th. Encompass Health’s dividend payout ratio (DPR) is presently 16.22%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.